Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677685 | 0.85 | CYP19A1 (0.38) | CYP19A1SMN1; SMN2GAASIGMAR1MEN1 | |
| SCHEMBL6676259 | 0.84 | CYP19A1 (0.40) | CYP19A1ACKR3SMN1; SMN2GAASIGMAR1 | |
| SCHEMBL6677679 | 0.82 | CYP19A1 (0.44) | CYP19A1SMN1; SMN2GAAMEN1KMT2A | |
| SCHEMBL6676251 | 0.81 | SMN1; SMN2 (0.40) | CYP19A1ACKR3SMN1; SMN2GAAMEN1 | |
| SCHEMBL6680873 | 0.78 | CYP1A2 (0.43) | CYP19A1SMN1; SMN2GAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6676735 | 0.77 | KMT2A (0.44) | CYP19A1SMN1; SMN2GAAMEN1KMT2A | |
| SCHEMBL6674882 | 0.76 | CFD (0.43) | SMN1; SMN2GAAAURKB | |
| SCHEMBL6679736 | 0.72 | GLS (0.46) | AURKAMEN1KMT2A | |
| SCHEMBL6677687 | 0.71 | SIGMAR1 (0.46) | CYP19A1SMN1; SMN2GAASIGMAR1MEN1 | |
| SCHEMBL10384268 | 0.70 | MAPT (0.42) | SMN1; SMN2GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0798292-B1 | ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY | CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) | 2004-11-03 | — | — | EP | claimed |
| EP-0798292-B1 | ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY | CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-6534546-B1 | Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-03-18 | — | — | US | disclosed |
| EP-0798292-A1 | ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY | Chugai Seiyaku Kabushiki Kaisha (JP) | 1997-10-01 | — | — | EP | disclosed |